
DUBLIN, Ohio — Health services firm Cardinal Health has extended its exclusive distribution agreement with a California company that’s developed a system to help track sponges used in surgical procedures.
The new agreement calls for Cardinal to co-market for the next five years the SurgiCount Safety-Sponge System from Temecula, California-based Patient Safety Technologies, according to a statement from the companies. Cardinal has been distributing the sponge-safety system since 2006.
Cardinal has placed a $10 million purchase order for SurgiCount products over the next year. As a deal sweetener, Cardinal will receive warrants from Patient Safety to purchase 1.25 million shares of the California firm’s common stock at $2 per share and another 625,000 shares at $4.
Patient Safety’s shares last traded at $1.70 on the over-the-counter bulletin board, a listing of stocks from companies that are often small, risky and unstable. In the third quarter, Patient Safety suffered a net loss of $3.3 million on revenue of $956,000.
“Our enhanced partnership solidifies the Safety-Sponge System as Cardinal Health’s preferred technology to help our customers protect their patients from retained foreign objects during surgeries,” said Steve Inacker, president of Cardinal Health’s clinical and procedural businesses.
The SurgiCount system aims to increase the accuracy of sponge counts performed in hospitals. The system works by labeling each sponge to be used in a procedure with a serial number embedded in a bar code. A counter is then used to scan and record the bar codes during initial and final sponge counts. Because each sponge is identified with a unique code, the system doesn’t allow the same sponge to be counted more than once, helping users obtain a more accurate sponge count, according to the statement.
In April 2008, Cardinal signed a distribution agreement with ClearCount Medical Solutions, a Pittsburgh company that has designed a system that uses radio frequency identification to count and detect surgery sponges. ClearCount’s system was the first sponge-counting and detection system to receive clearance from the U.S. Food and Drug Administration, according to a statement announcing the agreement.
However, ClearCount may have fallen out of favor with Cardinal. A Cardinal spokesman said bar code technology, which the SurgiCount system uses, is the company’s “preferred” means of tracking sponges because it’s less prone to outside interference than RFID.
Comments
Post a comment
Hey Med City – your coverage is biased and incomplete. Get with the program!
Your article is misleading because detection and not counting is the key. RF Surgical Inc. is the leader in sponge detection and is in way more hospitals (over 100) than Surgicount and uses many distributors including Cardinal for distribution of their “tagged” sponges. Cardinal says “preferred” techonology -very misleading. Preferred by whom?
Lewis L Bruggeman MD
Comment by Dr. Bruggeman — November 23, 2009 @ 5:02 pm
Dear Med City News,
I have dug a little deeper and I am hoping you will allow a second more in depth comment.
From a technical perspective, you article is misleading because detection technology and not counting is the LEADER in the Retained Foreign Object space that hospitals are so increasingly concerned about. RF Surgical Systems Inc. is the market leader and is in more hospitals than both of your mentioned counting technologies combined (over 100) and does use many distributors (in addition to Cardinal) for distribution of their “tagged†sponges.
Although Cardinal says “preferred technologyâ€, that is from Cardinal’s perspective, not those of clinicians. From SurgiCount’s last Quarterly financial report, it looks like without the support of their distributor, they would be out of business. Cardinal is issuing a PO for three years worth of product???. Good PR perhaps, but is sounds to me like Cardinal is trying to keep the company on life support!
Lewis L Bruggeman MD
Comment by Dr. Bruggeman — November 24, 2009 @ 4:51 pm
Post a Comment